Skip to main navigation
Skip to search
Skip to main content
University of Birmingham Home
Help & FAQ
Link opens in a new tab
Search content at University of Birmingham
Home
Research output
Profiles
Research units
Projects
Activities
Datasets
Equipment
Prizes
Press/Media
LifeArc Translational Rare Disease Centre RD-TAP
Calvert, Melanie
(Co-Investigator)
Blackburn, Steven
(Co-Investigator)
Billingham, Lucinda
(Co-Investigator)
Harper, Lorraine
(Co-Investigator)
Kearns, Pamela
(Co-Investigator)
Gates, Simon
(Co-Investigator)
Aiyegbusi, Lee
(Co-Investigator)
Trivedi, Palak
(Co-Investigator)
Gkoutos, Georgios
(Co-Investigator)
Homer, Victoria
(Co-Investigator)
Barrett, Timothy
(Principal Investigator)
Retzer, Ameeta
(Co-Investigator)
Higgs, Martin
(Co-Investigator)
Applied Health Sciences
Cancer Research UK Clinical Trials Unit
Immunology and Immunotherapy
Cancer and Genomic Sciences
Health Services Management Centre
Overview
Fingerprint
Research output
(1)
Project Details
Short title
LifeArc Translational Rare Disease Centre RD-TAP
Status
Active
Effective start/end date
1/09/24
→
31/08/29
Funding
LifeArc
View all
View less
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.
Outcome Assessment
Nursing and Health Professions
100%
Clinical Outcome
Nursing and Health Professions
100%
Rare Disease
Nursing and Health Professions
100%
Drug Development
Nursing and Health Professions
100%
Literature Review
Nursing and Health Professions
25%
Diseases
Nursing and Health Professions
25%
Clinical Trial
Nursing and Health Professions
25%
Drug Therapy
Nursing and Health Professions
25%
Research output
Research output per year
2026
2026
2026
1
Article
Research output per year
Research output per year
Recommendations for the use of clinical outcome assessments in rare disease drug development
Aiyegbusi, O. L.
,
Calvert, M. J.
,
Peipert, J. D.
,
Cruz Rivera, S.
,
Billingham, L.
,
McCabe, C.
,
Barrett, T. G.
&
LifeArc Accelerating Rare Disease Trials (ARDT) centre
,
29 Jun 2026
, (Accepted/In press)
In:
EClinicalMedicine.
Research output
:
Contribution to journal
›
Article
›
peer-review
Clinical Outcome
100%
Outcome Assessment
100%
Rare Disease
100%
Drug Development
100%
Drug Therapy
25%